Heghine Khachatryan: Empowering Women, Advancing Hemostasis, Transforming the Future
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared World Federation of Hemophilia’s post on LinkedIn, adding:
“Empowering Women. Advancing Hemostasis. Transforming the Future.
The recognition of eleven recipients of the Susan Skinner Memorial Fund (SSMF) Scholarship at the WFH 2026 World Congress is far more than a celebration of individual achievement-it is a testament to the growing leadership of women in the global bleeding disorders community.
The scholarship program aims to develop future leaders who will strengthen advocacy, education, research, and equitable access to care for women and girls with inherited bleeding disorders.
Women are no longer merely participants in the conversation; they are shaping international policies, advancing scientific research, improving clinical practice, and driving meaningful change within their countries and across the world.
As a hematologist, I strongly believe that sustainable progress in hemostasis depends on investing in leadership, scientific excellence, multidisciplinary collaboration, and the empowerment of women who transform knowledge into action.
Congratulations to all SSMF scholars.
Your dedication will undoubtedly contribute to a future where every woman and girl with a bleeding disorder receives timely diagnosis, comprehensive care, and equal opportunities—regardless of where she lives.
Together, we continue moving toward Treatment for All.”
World Federation of Hemophilia – WFH shared a post on LinkedIn:
“Women leaders are shaping the future of Bleeding Disorders care.
At the WFH 2026 World Congress, 11 recipients of the Susan Skinner Memorial Fund (SSMF) scholarships were recognized for their commitment to advancing care and advocacy.
Inspired by the experience, they are already planning initiatives, from supporting research to creating new opportunities for women and girls with bleeding disorders in their countries.
Read how these remarkable advocates are turning knowledge into action:”

Other posts featuring Heghine Khachatryan and World Federation of Hemophilia on Hemostasis Today.
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery